The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

A popular diabetes drug just got a major new approval — and it could be a game-changer for millions of Americans at risk for kidney failure.

Since kidney disease often progresses without noticeable symptoms in the early stages, its important to stay vigilant and ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

In a powerful act of love and sacrifice, Julie Malliet donated her kidney to her husband, Dave, who had been battling chronic kidney disease for years.

“There are some studies that show a lot of actually nutrition benefits to coffee,” said registered dietitian Ashley Hinds. A ...

Cardiovascular diseases claim more lives in the U.S. than all forms of cancer and accidental deaths combined, according to ...

Successful petitions to receive compassionate early release from federal prisons due to health issues are rare. They are even ...

Observational data fill a knowledge gap in the absence of randomized trials comparing empagliflozin vs dapagliflozin in patients with type 2 diabetes.

Raising taxes on alcohol and tobacco is a viable financing model to combat lifestyle diseases, as the high cost of treatment continues to burden low-income individuals suffering from non-communicable ...

The keto diet is a very low-carbohydrate, high-fat diet that aims to trigger a state called ketosis, in which the body ...

Humana and Monogram Health, a value-based multispecialty provider of in-home care and benefit management services for patients living with kidney disease, have expanded their partnership to patients ...